Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment.

Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K.

Respirology. 2018 Jul;23(7):656-673. doi: 10.1111/resp.13304. Epub 2018 Apr 11. Review.

2.

Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?

Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C.

Respirology. 2018 Jan;23(1):36-45. doi: 10.1111/resp.13143. Epub 2017 Aug 29. Review.

3.

Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications.

Mahomed S, Naidoo K, Dookie N, Padayatchi N.

Tuberculosis (Edinb). 2017 Dec;107:137-143. doi: 10.1016/j.tube.2017.09.005. Epub 2017 Sep 18. Review.

PMID:
29050762
4.

Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.

Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2013 Oct 25;62(RR-09):1-12. Erratum in: MMWR Recomm Rep. 2013 Nov 15;62(45):906.

5.

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.

Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, Trollip A, Hoek KG, Sirgel FA, Gey van Pittius NC, van Helden PD, Victor TC, Warren RM.

Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4. Review.

PMID:
21839855
6.

Multidrug-resistant tuberculosis.

Lemos AC, Matos ED.

Braz J Infect Dis. 2013 Mar-Apr;17(2):239-46. doi: 10.1016/j.bjid.2013.01.007. Epub 2013 Mar 9. Review.

7.

Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.

Lohrasbi V, Talebi M, Bialvaei AZ, Fattorini L, Drancourt M, Heidary M, Darban-Sarokhalil D.

Tuberculosis (Edinb). 2018 Mar;109:17-27. doi: 10.1016/j.tube.2017.12.002. Epub 2017 Dec 9. Review.

PMID:
29559117
9.

Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.

Hu Y, Mathema B, Zhao Q, Zheng X, Li D, Jiang W, Wang W, Xu B.

Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23.

PMID:
26980491
10.

Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.

Bonnet M, Bastard M, du Cros P, Khamraev A, Kimenye K, Khurkhumal S, Hayrapetyan A, Themba D, Telnov A, Sanchez-Padilla E, Hewison C, Varaine F.

Int J Tuberc Lung Dis. 2016 Feb;20(2):177-86. doi: 10.5588/ijtld.15.0962.

PMID:
26792469
11.

Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.

Chahine EB, Karaoui LR, Mansour H.

Ann Pharmacother. 2014 Jan;48(1):107-15. doi: 10.1177/1060028013504087. Epub 2013 Nov 1. Review.

PMID:
24259600
12.

Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.

Ahmad S, Mokaddas E.

Respir Med. 2009 Dec;103(12):1777-90. doi: 10.1016/j.rmed.2009.07.010. Epub 2009 Aug 5. Review.

13.

New treatment options for multidrug-resistant tuberculosis.

Field SK, Fisher D, Jarand JM, Cowie RL.

Ther Adv Respir Dis. 2012 Oct;6(5):255-68. Epub 2012 Jul 4. Review.

PMID:
22763676
14.

Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.

Rahman A, Ferdous SS, Ahmed S, Rahman SMM, Uddin MKM, Pholwat S, Gratz J, Houpt E, Banu S.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00511-17. doi: 10.1128/AAC.00511-17. Print 2017 Sep.

15.

Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.

Aung HL, Tun T, Moradigaravand D, Köser CU, Nyunt WW, Aung ST, Lwin T, Thinn KK, Crump JA, Parkhill J, Peacock SJ, Cook GM, Hill PC.

J Glob Antimicrob Resist. 2016 Sep;6:113-117. doi: 10.1016/j.jgar.2016.04.008. Epub 2016 May 30.

16.

Survey of tuberculosis drug resistance among Tibetan refugees in India.

Salvo F, Dorjee K, Dierberg K, Cronin W, Sadutshang TD, Migliori GB, Rodrigues C, Trentini F, Di Serio C, Chaisson R, Cirillo DM.

Int J Tuberc Lung Dis. 2014 Jun;18(6):655-62. doi: 10.5588/ijtld.13.0516.

PMID:
24903934
17.

Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage.

Chatterjee A, Nilgiriwala K, Saranath D, Rodrigues C, Mistry N.

Tuberculosis (Edinb). 2017 Dec;107:63-72. doi: 10.1016/j.tube.2017.08.002. Epub 2017 Aug 9.

PMID:
29050774
18.

[Management of multidrug-resistant tuberculosis].

Tritar F, Daghfous H, Ben Saad S, Slim-Saidi L.

Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):130-9. doi: 10.1016/j.pneumo.2014.05.001. Epub 2014 Aug 19. Review. French.

PMID:
25153927
19.

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.

20.

Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.

Dheda K, Chang KC, Guglielmetti L, Furin J, Schaaf HS, Chesov D, Esmail A, Lange C.

Clin Microbiol Infect. 2017 Mar;23(3):131-140. doi: 10.1016/j.cmi.2016.10.008. Epub 2016 Oct 15. Review.

Supplemental Content

Support Center